Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | TP53 | P04637 | 5/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 4/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.39 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | SDHB | P21912 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | MITF | O75030 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19805760 | 1.00 | KMT2A (0.43) | KMT2AMEN1TP53L3MBTL1SMN1; SMN2 | |
| SCHEMBL21019931 | 0.82 | ALDH1A1 (0.40) | KMT2AMEN1TP53L3MBTL1ALDH1A1 | |
| SCHEMBL20985663 | 0.80 | MEN1 (0.43) | KMT2AMEN1TP53L3MBTL1SMN1; SMN2 | |
| SCHEMBL21019879 | 0.80 | PDK1 (0.39) | KMT2AMEN1L3MBTL1SMN1; SMN2ALDH1A1 | |
| SCHEMBL20985700 | 0.79 | ALDH1A1 (0.39) | KMT2AMEN1TP53L3MBTL1SMN1; SMN2 | |
| SCHEMBL19805847 | 0.78 | SDHB (0.66) | KMT2AMEN1TP53SMN1; SMN2ALDH1A1 | |
| SCHEMBL19805930 | 0.77 | SDHB (0.57) | KMT2AMEN1TP53L3MBTL1SMN1; SMN2 | |
| SCHEMBL19806054 | 0.77 | KDM4E (0.60) | KMT2AMEN1TP53L3MBTL1SMN1; SMN2 | |
| SCHEMBL4718764 | 0.77 | MEN1 (0.49) | KMT2AMEN1TP53L3MBTL1SMN1; SMN2 | |
| SCHEMBL20985669 | 0.76 | KDM4E (0.61) | KMT2AMEN1TP53L3MBTL1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11725000-B2 | Apoptosis inhibitors | NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) | 2023-08-15 | — | — | US | disclosed |
| CN-110023292-B | Apoptosis inhibitors | 北京生命科学研究所 | 2022-10-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11725000-B2 | Apoptosis inhibitors | BAX, SDHA, SDHB | KMT2A 3060/4885MEN1 4080/4885TP53 160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.